Abstract
1527P Efficacy and safety of infigratinib in locally advanced or metastatic gastric cancer or gastroesophageal junction adenocarcinoma patients with FGFR2 gene amplification
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have